Geriatric
Medicine Market: Current Status, In-depth Analysis and Forecast Outlook 2031

The
geriatric medicines market is estimated to grow at a significant CAGR during
the forecast period. The primary factor related to the growth of the market is
a steep increase in the elderly population across geographical locations,
primarily in developed and emerging economies. Besides, the increasing
prevalence of chronic disorders, like cancers, diabetes, and rheumatoid
arthritis among the geriatrics attributes for the propel of the market. For
instance, as per the US data of World Population Prospects for the year 2019,
the number of people over the age of 65 raised from 9% in 2019 to more than 16%
of the total world’s population by 2050. The number of persons aged 80 years or
over is also anticipated to triple, from 143 million in 2019 to 426 million in
2050. Therefore, the increase in the volume of the patient pool results in a
higher demand for the market boosting the global market growth over the
forecast period.

Get Free Sample link @ https://www.omrglobal.com/request-sample/geriatric-medicine-market-share

The
analgesics segment is estimated to account for the most remarkable revenue over
the forecast period as it is the most common indication with a high happening
pain-related syndrome in the elder age. This dominance is due to the occurrence
of various reasons, like osteoporosis, lack of musculoskeletal strength, vision
impairment, and unintentional falls leading to uncontrollable pain in that age.

Full report of Geriatric Medicine Market available @ https://www.omrglobal.com/industry-reports/geriatric-medicine-market-share

Market
Coverage

• Segment Covered- 

o             By Therapeutic Category

o             By Condition

• Competitive Landscape:
  Endo Pharmaceuticals Inc., Merck & Co. Inc., AstraZeneca PLC, Pfizer
  Inc., and Allergan Inc.

Key
questions addressed by the report

• What is the market growth
  rate?


• Which segment and region
  dominates the market in base year?


• Which segment and region
  will project fastest growth in the market?


• How COVID-19 impacted the
  market?

o             Recovery Timeline

o             Deviation from pre-COVID forecast

o             Most affected region and segment

• Who is the leader in the
  market?


• How players are addressing
  challenges to sustain growth?


• Where is the investment
  opportunity?

Global
Geriatric Medicine Market by Segment

By
Therapeutic Category 

•                
Analgesics

•                
Antidiabetics

•                
Antihypertensives

•                
Antidepressant

•                
Other Therapeutic Categories

By
Condition

•                
Cardiovascular Diseases (CVDs)

•                
Diabetes

•                
Neurological

•                
Cancer

•                
Respiratory

•                
Others (Arthritis and Osteoporosis)

Reasons to Buying From us -



1. We cover more than 15 major industries, further segmented into more than 90
sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/geriatric-medicine-market-share

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.